Epigral is planning to establish a new manufacturing facility for Epoxy Resin & Formulations and Multi-Purpose Plant (MPP) at its existing facility at Dahej, Gujarat, as part of the company's strategic growth and expansion initiatives. The project entails an estimated investment of Rs 600 crore, with both facilities expected to be commissioned in the second half of FY28.
Epigral is primarily engaged in manufacturing and selling of Chlor Alkali & its Derivatives. The Company is also engaged in Trading of Agrochemical products.
| Company Name | CMP |
|---|---|
| SRF | 2640.95 |
| BASF India | 3749.10 |
| Pidilite Inds. | 1614.00 |
| Tata Chemicals | 681.50 |
| GNFC | 516.60 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: